Q2 2021 Holdings
Filed 2021-09-22 | 24 holdings | $11.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Beam Therapeutics Inc(BEAM) | COM | 07373V105 | $6.3M | 48,660 | 57.2% |
| Ardelyx Inc(ARDX) | COM | 039697107 | $2.5M | 325,233 | 22.5% |
| ALX Oncology Hldgs Inc(ALXO) | COM | 00166B105 | $1.9M | 34,950 | 17.5% |
| Eargo Inc | COM | 270087109 | $115.2K | 2,886,724 | 1.1% |
| New Frontier Health Corp | ORD SHS | G6461G106 | $93.3K | 8,350,000 | 0.9% |
| Karuna Therapeutics Inc | COM | 48576A100 | $26.8K | 234,811 | 0.2% |
| Harmony Biosciences Hldgs in(HRMY) | COM | 413197104 | $21.7K | 768,708 | 0.2% |
| Bolt Biotherapeutics Inc(BOLT1EUR) | COM | 097702104 | $18.0K | 1,166,952 | 0.2% |
| Galera Therapeutics Inc(GRTX) | COM | 36338D108 | $6.0K | 613,223 | 0.1% |
| Invitae Corp(NVTA1EUR) | COM | 46185L103 | $4.9K | 144,667 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $3.7K | 197,880 | 0.0% |
| New Frontier Health Corp | *W EXP 11/30/202 | G6461G114 | $3.7K | 1,580,000 | 0.0% |
| VIR Biotechnology Inc(VIR) | COM | 92764N102 | $3.2K | 68,663 | 0.0% |
| Sierra Oncology Inc | COM NEW | 82640U404 | $2.6K | 130,979 | 0.0% |
| Exact Sciences Corp(EXAS) | COM | 30063P105 | $2.2K | 17,464 | 0.0% |
| Otonomy Inc | COM | 68906L105 | $1.9K | 851,000 | 0.0% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $1.9K | 78,720 | 0.0% |
| DBV Technologies S A | SPONSORED ADR | 23306J101 | $1.6K | 285,500 | 0.0% |
| Rubius Therapeutics Inc | COM | 78116T103 | $1.4K | 56,768 | 0.0% |
| Reata Pharmaceuticals Inc(RETAEUR) | CL A | 75615P103 | $1.2K | 8,265 | 0.0% |
| Exelixis Inc(EXEL) | COM | 30161Q104 | $1.2K | 64,200 | 0.0% |
| Fluent Inc(IDIEUR) | COM | 34380C102 | $571 | 194,799 | 0.0% |
| Synlogic Inc | COM | 87166L100 | $267 | 68,634 | 0.0% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $86 | 3,470 | 0.0% |